Caalino Tablet (Calidino-genase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients who have recently suffered a brain hemorrhage or in patients with bleeding. Additionally, since this medication contains lactose, individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Allergic reactions may occur when taking this medication, and if skin rashes or itching develop, use should be discontinued immediately. Symptoms of a rapid heartbeat may also occur rarely, so caution is advised. Gastrointestinal issues such as stomach discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may be present. Other rare reports include feelings of heat, headaches, a heavy head, drowsiness, and fatigue. Particularly, older individuals may have decreased physical function, so careful management and possibly dose reduction are necessary when using this medication.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• epigastric pain
• diarrhea
• constipation

This medication should be stored in a sealed container to prevent air exposure and is best kept at a temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the drug for a longer period.

Appearance

Red round enteric-coated tablet

Package unit

30 tablets, 300 tablets